First-lineAdenocor
Adenosine
Purinergic A1 receptor agonist / AV nodal blocker
First-line for stable maternal SVT — safe every trimester.
IV rapid push
First-line for
- Stable narrow-complex SVT in pregnancy
- Diagnostic unmasking of AF/flutter
Mechanism
Transient A1 activation hyperpolarises AV node → block re-entrant SVT circuits; half-life <10 s.
"6-12-12, flush fast"
- 6 mg → 12 mg → 12 mg via large-bore proximal cannula
- Warn patient of chest tightness, doom feeling
- Halve dose on dipyridamole or heart transplant
Dosing
- First dose
- 6 mg IV rapid push + 20 mL saline flush
- Second/third
- 12 mg if no response
Contraindications
- Absolute2°/3° AV block without pacemaker
- AbsoluteSevere asthma (bronchospasm)
- AbsoluteLong QT / decompensated HF
Side effects
- Chest tightness, flushing, dyspnoea (seconds)
- Transient asystole
- Bronchospasm (asthma)
- Sinus pause
Fetal & maternal notes
- • Half-life <10 s → negligible placental transfer
- • Safe every trimester
Key interactions
Dipyridamole
AvoidPotentiates — halve dose
Theophylline / caffeine
CautionAntagonise — may need higher dose
Clinical pearls
- 💡 Do vagal manoeuvres first (Valsalva, modified REVERT)
- 💡 Have defibrillator and airway ready
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.